文献速递神经技术与安全MR

重复给予钆基对比剂后大鼠脑内残留钆的定量及化学形式评估:比较研究

Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats.
PubMed 文献 · Invest Radiol · 2017-01-01

该大鼠脑组织生物分析研究将大鼠随机分为6组,每组10只,分别接受5种钆基对比剂(线性:钆双胺、钆喷酸葡胺、钆贝葡胺;大环状:钆布醇、钆特酸葡胺)或生理盐水,每日注射2.5 mmol/kg体重,共10次,于末次注射后第3天和第24天处死,采用组织分级分离和色谱法分析脑内残留钆的化学形式。结果显示线性剂组钆大量存在于不溶性组分,并有大分子结合,大环状剂组钆仅以可溶性小分子形式存在且浓度较低,提示大环状剂的动力学惰性对防止脑内钆滞留至关重要。

要点

  • 大环状钆剂脑内钆仅以可溶性小分子形式存在,浓度较低。
  • 线性钆剂脑内钆大量存在于不溶性组分,并有大分子结合形式。
  • 线性剂组不溶性钆和大分子钆可能与MRI持续信号增强有关。

核心结论

  • 重复给予3种线性钆剂后大鼠脑内残留钆至少以3种形式存在:可溶性小分子(包括完整钆剂)、可溶性大分子和大量不溶性形式,后两者最可能导致MRI观察到的脑结构信号强度持续增强;大环状钆剂脑内钆浓度较低且仅为可溶性小分子,缓慢排泄,凸显其动力学惰性对防止脑内钆滞留的关键重要性。

研究设计与样本

  • 大鼠随机分为6组,每组10只,分别接受10次每日注射2.5 mmol/kg体重的5种钆基对比剂之一(线性:钆双胺、钆喷酸葡胺、钆贝葡胺;大环状:钆布醇、钆特酸葡胺)或生理盐水;于末次注射后第3天和第24天每组随机选5只处死,取脑分为大脑、脑桥和小脑,经超声匀浆、离心分离可溶性和不溶性组分,可溶性组分进一步行凝胶渗透色谱,电感耦合等离子体质谱测定钆浓度;回收率对照实验显示组织组分中钆回收率超过94%。

局限性

  • 含钆大分子和不溶性形式的性质未确定。
  • 含钆大分子和不溶性形式似乎可饱和。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: Multiple clinical and preclinical studies have reported a signal intensity increase and the presence of gadolinium (Gd) in the brain after repeated administration of Gd-based contrast agents (GBCAs). This bioanalytical study in rat brain tissue was initiated to investigate whether the residual Gd is present as intact GBCA or in other chemical forms by using tissue fractionation and chromatography.

MATERIALS AND METHODS: Rats were divided randomly in 6 groups of 10 animals each. They received 10 daily injections of 2.5 mmol/kg bodyweight of 1 of 5 different GBCAs: linear GBCAs such as gadodiamide (Omniscan; GE Healthcare), gadopentetate dimeglumine (Gd-DTPA, Magnevist; Bayer), or gadobenate dimeglumine (Multihance; Bracco) and macrocyclic GBCAs such as gadobutrol (Gadovist; Bayer) and gadoterate meglumine (Gd-DOTA, Dotarem; Guerbet) or saline. On days 3 and 24 after the last injection (p.i.), 5 randomly chosen animals of each group were killed by exsanguination, and their brains were excised and divided into cerebrum, pons, and cerebellum. The brain sections were homogenized by sonication in ice-cold buffer at pH 7.4. Soluble and insoluble fractions were separated by centrifugation, and the soluble fractions were further separated by gel permeation chromatography (GPC). The Gd concentration in all tissue fractions and in the GPC eluate was measured by inductively coupled plasma-mass spectrometry. In a recovery control experiment, all GBCAs were spiked to blank brain tissue and more than 94% recovery of Gd in the tissue fractions was demonstrated.

RESULTS: Only traces of the administered Gd were found in the rat brain tissue on day 3 and day 24 p.i. In the animals treated with macrocyclic GBCAs, Gd was found only in the soluble brain fraction and was present solely as low molecular weight molecules, most likely the intact GBCA. In the animals treated with linear GBCAs Gd was found to a large extent in the insoluble tissue fraction. The Gd concentration in the soluble fraction was comparable to the macrocyclic agents. According to GPC, a smaller portion of the Gd in the soluble fraction of the linear GBCAs groups was bound to macromolecules larger than 250 to 300 kDa. The nature of the Gd-containing macromolecules and the insoluble species were not determined, but they appeared to be saturable with Gd. The excretion of the soluble Gd species in the linear and macrocyclic GBCA groups was still ongoing between days 3 and 24 p.i. This was also observed for the macromolecular Gd species in the linear GBCA groups, but at a slower rate.

CONCLUSIONS: The residual Gd found in the rat brain after repeated administration of all 3 linear GBCAs was present in at least 3 distinctive forms-soluble small molecules, including the intact GBCA, soluble macromolecules, and to a large extent in insoluble form. The latter 2 are most likely responsible for the prolonged signal intensity enhancement in brain structures observed in magnetic resonance imaging. No relevant differences between the 3 linear GBCAs were observed. The Gd concentrations in the brain after administration of macrocyclic GBCAs are lower, and the Gd is only present in soluble small molecules, which were slowly excreted. This underlines the crucial importance of the kinetic inertness of macrocyclic agents in the prevention of potential retention of Gd in the brain compared with the 3 linear, kinetically less restricted GBCAs.

来源:Invest Radiol,查看原文。版权归原作者所有。

引用

  1. Frenzel T, Apte C, Jost G, et al. Quantification and Assessment of the Chemical Form of Residual Gadolinium in the Brain After Repeated Administration of Gadolinium-Based Contrast Agents: Comparative Study in Rats. Invest Radiol. 2017. PMID: 28125438. doi:10.1097/RLI.0000000000000352

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。